Prediction of Alzheimer's disease diagnosis within 14 years through Aβ misfolding in blood plasma compared to APOE4 status, and other risk factors
Introduction: Alzheimer's disease (AD) has a long prodromal stage and identifying high-risk individuals is critical. We aimed to investigate the ability of A beta misfolding in blood plasma, APOE4 status, and dementia risk factors to predict diagnosis of AD. Methods: Within a community-based co...
Salvato in:
| Autori principali: | , , , , , , , , , |
|---|---|
| Natura: | Article (Journal) |
| Lingua: | inglese |
| Pubblicazione: |
6 January 2020
|
| In: |
Alzheimer's and dementia
Year: 2020, Volume: 16, Fascicolo: 2, Pages: 283-291 |
| ISSN: | 1552-5279 |
| DOI: | 10.1016/j.jalz.2019.08.189 |
| Accesso online: | Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.jalz.2019.08.189 |
| Note sull'autore: | Hannah Stocker, Andreas Nabers, Laura Perna, Tobias Möllers, Dan Rujescu, Annette Hartmann, Bernd Holleczek, Ben Schöttker, Klaus Gerwert, Hermann Brenner |
| Riassunto: | Introduction: Alzheimer's disease (AD) has a long prodromal stage and identifying high-risk individuals is critical. We aimed to investigate the ability of A beta misfolding in blood plasma, APOE4 status, and dementia risk factors to predict diagnosis of AD. Methods: Within a community-based cohort, A beta misfolding in plasma measured by immuno-infrared sensor and APOE genotypewere determined at baseline in 770 participants followed over 14 years. Associations between A beta misfolding, APOE4, and other predictors with clinical AD, vascular dementia, and mixed dementia diagnoses were assessed. Results: A beta misfolding was associated with a 23-fold increased odds of clinical AD diagnosis within 14 years. No association was observed with vascular dementia/mixed dementia diagnoses. APOE4-positive participants had a 2.4-fold increased odds of clinical AD diagnosis within 14 years. Discussion: A beta misfolding in blood plasma was a strong, specific risk prediction marker for clinical AD evenmany years before diagnosis in a community-based setting. |
|---|---|
| Descrizione del documento: | Gesehen am 07.07.2020 |
| Descrizione fisica: | Online Resource |
| ISSN: | 1552-5279 |
| DOI: | 10.1016/j.jalz.2019.08.189 |